2022
DOI: 10.31083/j.fbs1403023
|View full text |Cite
|
Sign up to set email alerts
|

The Role of the Gut-Lung Axis in COVID-19 Infections and Its Modulation to Improve Clinical Outcomes

Abstract: The main entry point of SARS-CoV-2 is the respiratory tract and as such immune defence in this site determines if the virus will spillover to the systemic circulation and circulate and infect other major organs. The first line of mucosal immune defence is composed of mucins, an epithelial barrier, and immune cells in the nasal cavity. The lung immune defence is carried out by numerous alveoli. The lung microbiota is a key factor in determining the efficacy of lung mucosal immunity protection. The intestinal mi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 170 publications
(222 reference statements)
0
2
0
Order By: Relevance
“…These changes can have a serious impact on the health of the survivor, causing an inflammatory immune response in the body, changes in the levels of basal metabolite levels (e.g., amino acids, carbohydrates, and neurotransmitters), and clinical gastrointestinal symptoms [ 114 ]. Gut microflora dysbiosis can have neurological and pulmonary effects through cytokines and metabolites [ 115 ], which are mediated through the gut–lung and brain–gut axes [ 116 , 117 ].…”
Section: Therapeutic Potential Of Naringin and Naringenin In Long Covidmentioning
confidence: 99%
“…These changes can have a serious impact on the health of the survivor, causing an inflammatory immune response in the body, changes in the levels of basal metabolite levels (e.g., amino acids, carbohydrates, and neurotransmitters), and clinical gastrointestinal symptoms [ 114 ]. Gut microflora dysbiosis can have neurological and pulmonary effects through cytokines and metabolites [ 115 ], which are mediated through the gut–lung and brain–gut axes [ 116 , 117 ].…”
Section: Therapeutic Potential Of Naringin and Naringenin In Long Covidmentioning
confidence: 99%
“…Gut dysbiosis can lead to gut inflammation and increased gut permeability, allowing translocations of gut bacteria, bacterial components such as LPS, metabolites, pathogenassociated molecular patterns (PAMPs), cell wall components, and flagellin into the circulation and the lung, contributing to changes in lung immunity, including dysregulation of lung immune response by increasing inflammatory markers and T cell dysregulation. Dysbiosis contributes to an altered immune response, altered microbiota (a decrease in microbial diversity and pathogen multiplication), and tissue damage [139,140]. Microbial dysbiosis is associated with numerous lung diseases such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, and COVID-19; however, it is unclear whether gut dysbiosis is the cause of disease or a consequence of the disease process.…”
Section: Gut Dysbiosis In Pulmonary Diseasesmentioning
confidence: 99%